Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment.

[1]  N. Lee,et al.  Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events. , 2008, Journal of substance abuse treatment.

[2]  B. Mégarbane,et al.  Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  C. O'brien.  A 50-year-old woman addicted to heroin: review of treatment of heroin addiction. , 2008, JAMA.

[4]  W. Klein-Schwartz,et al.  Toxicity of Buprenorphine Overdoses in Children , 2008, Pediatrics.

[5]  Jason M. White,et al.  Exposure to opioid maintenance treatment reduces long-term mortality. , 2008, Addiction.

[6]  M. Auriacombe,et al.  Why buprenorphine is so successful in treating opiate addiction in France , 2007, Current psychiatry reports.

[7]  K. Kielland,et al.  Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers--a competing risk approach. , 2007, Drug and alcohol dependence.

[8]  L. Degenhardt,et al.  Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records. , 2007, Drug and alcohol review.

[9]  Albert Dahan,et al.  Naloxone treatment in opioid addiction: the risks and benefits , 2007, Expert opinion on drug safety.

[10]  M. Danhof,et al.  Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by Naloxone , 2007, Clinical pharmacokinetics.

[11]  H. Wittchen,et al.  One-year Mortality Rates of Patients Receiving Methadone and Buprenorphine Maintenance Therapy: A Nationally Representative Cohort Study in 2694 Patients , 2006, Journal of clinical psychopharmacology.

[12]  S. Lai,et al.  A survey of buprenorphine related deaths in Singapore. , 2006, Forensic science international.

[13]  M. Danhof,et al.  Buprenorphine induces ceiling in respiratory depression but not in analgesia. , 2006, British journal of anaesthesia.

[14]  M. Soyka,et al.  Fatal Poisoning in Methadone and Buprenorphine Treated Patients - Are there Differences? , 2006, Pharmacopsychiatry.

[15]  M. Danhof,et al.  Naloxone Reversal of Buprenorphine-induced Respiratory Depression , 1988, Anesthesiology.

[16]  B. Mégarbane,et al.  Does High-Dose Buprenorphine Cause Respiratory Depression? , 2006, Toxicological reviews.

[17]  F. Vocci,et al.  Medication development for addictive disorders: the state of the science. , 2005, The American journal of psychiatry.

[18]  B. Mégarbane,et al.  Flunitrazepam does not alter cerebral distribution of buprenorphine in the rat. , 2005, Toxicology letters.

[19]  M. Danhof,et al.  Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. , 2005, British journal of anaesthesia.

[20]  F. Baud,et al.  A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. , 2004, Addiction.

[21]  K. Sporer.  Buprenorphine: a primer for emergency physicians. , 2004, Annals of emergency medicine.

[22]  P. Mehler,et al.  Treating opioid dependence: Growing implications for primary care , 2004 .

[23]  T. Randell,et al.  Serious overdoses involving buprenorphine in Helsinki , 2003, Acta anaesthesiologica Scandinavica.

[24]  B. Mégarbane,et al.  Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995-99. , 2002, Addiction.

[25]  E. Vicaut,et al.  Mechanism of Respiratory Insufficiency in Pure or Mixed Drug-Induced Coma Involving Benzodiazepines , 2002, Journal of toxicology. Clinical toxicology.

[26]  P. Kintz.  Buprenorphine-Related Deaths , 2002 .

[27]  M. Debray,et al.  Buprenorphine and midazolam act in combination to depress respiration in rats. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  P. Kintz.  Deaths involving buprenorphine: a compendium of French cases. , 2001, Forensic science international.

[29]  M. Debray,et al.  Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  E. Strain,et al.  Treating opioid dependence. , 2001 .

[31]  D. Mathieu,et al.  Flumazenil Use in an Emergency Department: A Survey , 2001, Journal of toxicology. Clinical toxicology.

[32]  B. Ludes,et al.  Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. , 1998, Journal of analytical toxicology.

[33]  E. Vicaut,et al.  Empiric use of flumazenil in comatose patients: limited applicability of criteria to define low risk. , 1996, Annals of emergency medicine.

[34]  K. Preston,et al.  Clinical pharmacology of buprenorphine: Ceiling effects at high doses , 1994, Clinical pharmacology and therapeutics.

[35]  D. Schriger,et al.  The empiric use of naloxone in patients with altered mental status: a reappraisal. , 1989, Annals of emergency medicine.

[36]  T. Gal.  Naloxone reversal of buprenorphine‐induced respiratory depression , 1989, Clinical pharmacology and therapeutics.

[37]  A. Cowan,et al.  THE ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT , 1977, British journal of pharmacology.

[38]  B. Berkowitz.  The Relationship of Pharmacokinetics to Pharmacological Activity: Morphine, Methadone and Naloxone , 1976, Clinical pharmacokinetics.